About Lorelei Integrated Therapeutics
Lorelei Integrated Therapeutics is a company based in Houston (United States) founded in 2020. Lorelei Integrated Therapeutics has raised $1.04 million across 1 funding round.
- Headquarter Houston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.04 M (USD)
in 1 rounds
-
Latest Funding Round
$1.04 M (USD), Seed
Jun 29, 2022
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Lorelei Integrated Therapeutics
Lorelei Integrated Therapeutics has successfully raised a total of $1.04M through 1 strategic funding round. The most recent funding activity was a Seed round of $1.04 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Lorelei Integrated Therapeutics
Investment portfolio details for Lorelei Integrated Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Lorelei Integrated Therapeutics
Detailed financials for Lorelei Integrated Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lorelei Integrated Therapeutics Comparisons
Peer comparison for Lorelei Integrated Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lorelei Integrated Therapeutics
Detailed competitors of Lorelei Integrated Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lorelei Integrated Therapeutics
Complete news archive for Lorelei Integrated Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lorelei Integrated Therapeutics
Lorelei Integrated Therapeutics was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Lorelei Integrated Therapeutics is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Lorelei Integrated Therapeutics is a funded company, having raised a total of $1.04M across 1 funding round to date.
Lorelei Integrated Therapeutics was founded in 2020 and is based in Houston, United States. Operations focus on the extraction and concentration of cannabinoid acids within the therapeutics sector. Services are tailored for integrated processing needs in the cannabinoid industry. The company supports research and development efforts through specialized handling techniques. Geographic emphasis remains on the U.S. market, with potential for broader applications in pharmaceutical advancements.